EIM
ABEO icon

Essex Investment Management’s Abeona Therapeutics ABEO Stock Holding History

Essex Investment Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,539
Closed -$656K – 356
2017
Q3 		$656K Sell
1,539
-2,175
-59% -$584K 0.09% 247
2017
Q2 		$594K Buy
+3,714
New +$507K 0.09% 244

Other funds holding ABEO

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return

Essex Investment Management's ABEO Position: Q4 2017 in Review

Essex Investment Management sold out of Abeona Therapeutics (ABEO) in Q4 2017, closing a stake of 1,539 shares — an estimated $656K sold.

Essex Investment Management first reported a position in ABEO in Q2 2017 and held it in 2 quarters. The position peaked at $656K in Q3 2017. 93 funds tracked by Wall St. Rank hold ABEO as of Q4 2017.

  • Essex Investment Management reported no remaining Abeona Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Essex Investment Management sold 1,539 Abeona Therapeutics shares in Q4 2017, an estimated $656K.
  • Essex Investment Management first reported a position in Abeona Therapeutics in Q2 2017 and held it in 2 quarters.
  • Essex Investment Management's Abeona Therapeutics position peaked at $656K in Q3 2017.
  • 93 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2017.

Based on Essex Investment Management's 13F filing for Q4 2017, filed 5 Feb 2018.